SCHEDULE 3 Amendments consequential on the establishment of the National Health Service Commissioning Board and clinical commissioning groups

The Medicines for Human Use (Clinical Trials) Regulations 2004

8.—(1) The Medicines for Human Use (Clinical Trials) Regulations 2004(1) are amended as follows.

(2) In regulation 2(1) (interpretation), in the definition of “health service body”—

(a) in paragraph (b), after “Primary Care Trust” insert “, clinical commissioning group”; and

(b) after paragraph (b) insert—

“(ba) the National Health Service Commissioning Board,”.

(3) In Schedule 2 (additional provisions relating to Ethics Committees)—

(a) in paragraph 3(5)(b)(iii), at the end of paragraph (bb) insert—

“; or

(cc) the governing body of a clinical commissioning group”; and

(b) in paragraph 6(6)(a)(ii), after “health service body” insert “or the governing body of a clinical commissioning group”.

(1)

S.I. 2004/1031. Relevant amending instruments are S.I. 2006/562, S.I. 2008/941 and S.I. 2011/2581.